Skip to main content
Top

International Journal of Hematology

Issue 2/2017

Including PIH Articles on Familial predisposition of myeloid malignancies: Biological and clinical signifcances of recurrent germline mutations

Content (22 Articles)

Images in Hematology

Diffuse large B-cell lymphoma with a bulky mass in the cranial vault

Minoru Kanaya, Tomoyuki Endo, Daigo Hashimoto, Shogo Endo, Ryo Takemura, Kohei Okada, Kanako C. Hatanaka, Yoshihiro Matsuno, Takanori Teshima

Images in Hematology

Marked hypereosinophilia and rash as initial presentation of acute myeloid leukemia with t(8;21)

Shin Yeu Ong, Liam Pock Ho, Pei Ming Yeo, Heng Joo Ng, Ai Leen Ang

Progress in Hematology

Myeloid neoplasms with germline DDX41 mutation

Jesse J. C. Cheah, Christopher N. Hahn, Devendra K. Hiwase, Hamish S. Scott, Anna L. Brown

Progress in Hematology

Heterogeneity of GATA2-related myeloid neoplasms

Shinsuke Hirabayashi, Marcin W. Wlodarski, Emilia Kozyra, Charlotte M. Niemeyer

Progress in Hematology

Myeloid neoplasms with germ line RUNX1 mutation

Yoshihiro Hayashi, Yuka Harada, Gang Huang, Hironori Harada

Progress in Hematology

Germline ETV6 mutations and predisposition to hematological malignancies

Simone Feurstein, Lucy A. Godley

Original Article

Hepcidin suppression in β-thalassemia is associated with the down-regulation of atonal homolog 8

Supranee Upanan, Andrew T. McKie, Gladys O. Latunde-Dada, Sittiruk Roytrakul, Chairat Uthaipibull, Peraphan Pothacharoen, Prachya Kongtawelert, Suthat Fucharoen, Somdet Srichairatanakool

Original Article

Clinical usefulness of the dilute Russell viper venom time test for patients taking warfarin

Kazunori Kanouchi, Hiroto Narimatsu, Okio Ohnuma, Keita Morikane, Akira Fukao

Original Article

SOX11 regulates the pro-apoptosis signal pathway and predicts a favorable prognosis of mantle cell lymphoma

Wenjuan Yang, Yanying Wang, Zhen Yu, Zengjun Li, Gang An, Wei Liu, Rui Lv, Liping Ma, Shuhua Yi, Lugui Qiu

Original Article

Primary fungal prophylaxis in acute leukemia patients with different risk factors: retrospective analysis from the CAESAR study

Rongli Zhang, Jing Chen, He Huang, Jun Ma, Fanyi Meng, Yongmin Tang, Jianda Hu, Xi Zhang, Yu Ji, Huisheng Ai, Yingmin Liang, Depei Wu, Xiaojun Huang, Mingzhe Han

Original Article

Analysis of adverse events associated with dasatinib and nilotinib treatments in chronic-phase chronic myeloid leukemia patients outside clinical trials

Koung Jin Suh, Ji Yun Lee, Dong-Yeop Shin, Youngil Koh, Soo-Mee Bang, Sung-Soo Yoon, Seonyang Park, Inho Kim, Jeong-Ok Lee

Original Article

Ofatumumab combined with chlorambucil for previously untreated chronic lymphocytic leukemia: a phase I/II, open-label study in Japan

Kiyohiko Hatake, Michinori Ogura, Kohichi Takada, Masafumi Taniwaki, Fanghong Zhang, Taizo Fujita, Kiyoshi Ando

Original Article

Iron overload may promote alteration of NK cells and hematopoietic stem/progenitor cells by JNK and P38 pathway in myelodysplastic syndromes

Yanni Hua, Chaomeng Wang, Huijuan Jiang, Yihao Wang, Chunyan Liu, Lijuan Li, Hui Liu, Zonghong Shao, Rong Fu

Original Article

MicroRNA-192 regulates cell proliferation and cell cycle transition in acute myeloid leukemia via interaction with CCNT2

Shun Ke, Rui-chao Li, Jun Lu, Fan-kai Meng, Yi-kuan Feng, Ming-hao Fang

Original Article

Prophylactic use of octreotide for asparaginase-induced acute pancreatitis

Sachi Sakaguchi, Takeshi Higa, Mitsuyoshi Suzuki, Junya Fujimura, Toshiaki Shimizu

Original Article

EP300-ZNF384 fusion gene product up-regulates GATA3 gene expression and induces hematopoietic stem cell gene expression signature in B-cell precursor acute lymphoblastic leukemia cells

Akinori Yaguchi, Takeshi Ishibashi, Kazuki Terada, Hitomi Ueno-Yokohata, Yuya Saito, Junya Fujimura, Toshiaki Shimizu, Kentaro Ohki, Atsushi Manabe, Nobutaka Kiyokawa

Original Article

Exome sequencing for simultaneous mutation screening in children with hemophagocytic lymphohistiocytosis

Ekchol Mukda, Objoon Trachoo, Ekawat Pasomsub, Rawiphorn Tiyasirichokchai, Nareenart Iemwimangsa, Darintr Sosothikul, Wasun Chantratita, Samart Pakakasama

Original Article

Bortezomib combined with standard induction chemotherapy in Japanese children with refractory acute lymphoblastic leukemia

Akihiro Iguchi, Yuko Cho, Minako Sugiyama, Yukayo Terashita, Tadashi Ariga, Yosuke Hosoya, Shinsuke Hirabayashi, Atsushi Manabe, Keisuke Hara, Tetsuya Aiba, Tsugumi Shiokawa, Hiroko Tada, Norihiro Sato

Case Report

Successful treatment of histiocytic sarcoma with cladribine and high-dose cytosine arabinoside in a child

Haruko Iwabuchi, Hiroyuki Kawashima, Hajime Umezu, Takayuki Takachi, Masaru Imamura, Akihiko Saitoh, Akira Ogose, Chihaya Imai

Erratum

Erratum to: Primary fungal prophylaxis in acute leukemia patients with different risk factors: retrospective analysis from the CAESAR study

Rongli Zhang, Jing Chen, He Huang, Jun Ma, Fanyi Meng, Yongmin Tang, Jianda Hu, Xi Zhang, Yu Ji, Huisheng Ai, Yingmin Liang, Depei Wu, Xiaojun Huang, Mingzhe Han

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine